Co-Diagnostics Joint Venture CoSara to Showcase at VIROCON 2025 in India
Co-Diagnostics, Inc., a molecular diagnostics company, announced that its joint venture, CoSara Diagnostics Pvt. Ltd., will participate in VIROCON 2025 in Pune, India. CoSara will host a booth at the event, which is organized by the India Council of Medical Research - National Institute of Virology. The company is currently advancing its preclinical studies for the Co-Dx PCR MTB and HPV tests. These studies are part of the preparation for clinical performance testing required by Indian regulatory authorities. The Co-Dx PCR MTB test is designed for tuberculosis detection, while the HPV test targets eight different human papillomavirus genotypes. The event aims to foster scientific discussions and collaborations to address viral epidemics affecting human, animal, and environmental health. 
